UNIVERSITÉ DE GENÈVE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 2445
 
  
 
H04L TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 2283
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
G06T IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1134
 
  
 
H04N PICTORIAL COMMUNICATION, e.g. TELEVISION 1241

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0319,673 TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORSNov 12, 15Nov 09, 17[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9809801 Anti-mycobacterial vaccinesMar 14, 14Nov 07, 17[A61K, C07H, C12N]
9794067 Method for active content fingerprintingSep 18, 13Oct 17, 17[H04L, H04N, G06T, G06F]
9747077 Method and device for optics based quantum random number generationApr 27, 15Aug 29, 17[G06N, H04L, G06F]
9708279 2-acylaminothiazoles for the treatment of cancerJul 03, 14Jul 18, 17[A61K, C07F, C07D]
9556433 Nucleic acids for down-regulation of gene expressionSep 13, 13Jan 31, 17[C12N]
9511226 Device and method for electrical stimulation of neural or muscular tissueJan 24, 14Dec 06, 16[A61N]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.